Mark Erlander
Chief Executive Officer, Director at Cardiff Oncology, Inc. (CRDF)
Mark Erlander has filed 7 insider reports with the SEC since March 2021, as chief Executive Officer and director at Cardiff Oncology, Inc. (CRDF). Mark Erlander made no open-market purchases or sales in the last 12 months. The latest filing, on March 13, 2025, reports grant or award at Cardiff Oncology, Inc. (CRDF).
- Filings
- 7
- Companies
- 1
- Bought on market
- $24.3K
- Sold on market
- None
Companies where Mark Erlander is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 24,481 | $24.3K | $2.21 | $0.839-62% | Mar 13, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Mar 11, 2025CRDFSEC Form 4 filed by Chief Executive Officer Erlander MarkForm 4Grant or award
- Mar 7, 2024CRDFSEC Form 4 filed by Erlander MarkForm 4Grant or award
- Mar 15, 2023CRDFSEC Form 4 filed by Erlander MarkForm 4Grant or award
- Nov 25, 2022+$14.3KCRDFSEC Form 4: Erlander Mark bought $14,300 worth of shares (10,000 units at $1.43), increasing direct ownership by 69% to 24,481 unitsForm 4Open-market purchase
- Mar 9, 2022CRDFSEC Form 4 filed by Erlander MarkForm 4Grant or award
- Jun 10, 2021CRDFSEC Form 4 filed by Erlander MarkForm 4Grant or award
- Mar 23, 2021+$9,980CRDFSEC Form 4: Mark Erlander bought $9,980 worth of Common Stock (965 units at $10.34), increasing direct ownership by 7% to 14,481 unitsForm 4Open-market purchase
Compare Mark Erlander with
- Mark Erlander vs Gary W Pace1 shared
- Mark Erlander vs Mani Mohindru1 shared
- Mark Erlander vs Renee P Tannenbaum1 shared
- Mark Erlander vs Rodney S Markin1 shared
- Mark Erlander vs Lale White1 shared
- Mark Erlander vs James O Armitage1 shared
Other insiders at the same companies
- Gary W PaceCRDF
- Mani MohindruCRDF
- Renee P TannenbaumCRDF
- Rodney S MarkinCRDF
- Lale WhiteCRDF
- James O ArmitageCRDF
- Ajay AggarwalCRDF
- Joshua B MuntnerCRDF
- Tod SmealCRDF
- Brigitte Ute LindsayCRDF
- Roger SidhuCRDF
- Fairooz KabbinavarCRDF
- James E. LevineCRDF
Questions about Mark Erlander
- What is Mark Erlander's role at Cardiff Oncology, Inc.?
- Mark Erlander reports to the SEC as chief Executive Officer and director at Cardiff Oncology, Inc. (CRDF), according to the latest filing on March 13, 2025.
- How many shares does Mark Erlander own?
- After the latest filing that states it, Mark Erlander directly owned 24,481 shares of Cardiff Oncology, Inc. (CRDF). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Erlander bought or sold stock recently?
- The most recent open-market purchase was on November 25, 2022: bought 10,000 shares of Cardiff Oncology, Inc. (CRDF) for $14.3K at an average of $1.43.
- How do I get alerts when Mark Erlander files?
- Follow Mark Erlander on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Erlander (SEC CIK 0001651537). Totals count each trade once, skipping amendments whose original is on file, from Mar 23, 2021 on. View on SEC EDGAR